comparemela.com
Home
Live Updates
Kite Pharma, Daiichi Sankyo revise YESCARTA CAR T-Cell Therapy licensing agreement : comparemela.com
Kite Pharma, Daiichi Sankyo revise YESCARTA CAR T-Cell Therapy licensing agreement
Tokyo: Kite Pharma, Inc., a Gilead Company, (hereafter Kite), and Daiichi Sankyo Co., Ltd. have jointly announced the revision of their 2017 partnership agreement, which gave Daiichi Sankyo ...
Related Keywords
California ,
United States ,
Japan ,
Tokyo ,
El Segundo ,
Japanese ,
Christi Shaw ,
Shoji Hirashima ,
Daiichi Sankyo ,
Kite Pharma Inc ,
Daiichi Sankyo Co Ltd ,
Gilead Company ,
Gilead Sciences ,
Gilead Sciences Inc ,
Kite Pharma ,
Marketing Authorization ,
Kite Cell ,
Therapy Business Unit ,
Senior Executive Officer ,
Japan Business Unit ,
Yescarta ,
Axicabtagene Ciloleucel ,
comparemela.com © 2020. All Rights Reserved.